RxDoctor Payments Data

James Waldman, MD

MOHS-Micrographic Surgery · Irvine, CANPI 1619011764

Payments from drug & device makers

$544in general payments, 2019–2025

Across 8 payments — averaging $68.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$204
  • Lilly USA, LLC$122
  • AbbVie$120
  • Bristol Myers Squibb$51
  • UCB, Inc.$48

What the payments were for

  • Travel & lodging$20%
  • Food & beverage$52797%
  • Education$153%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer3$204
Lilly USA, LLC2$122
AbbVie1$120
Bristol Myers Squibb1$51
UCB, Inc.1$48

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$544 in reported general payments places this provider in the 20th percentile of 144 mohs-micrographic surgery providers in California.

See all mohs-micrographic surgery providers in California

Medicare billing

Part B allowed, 2024
$476,953
Medicare patients
661
Services billed
6,318

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxistatOxiconazole Nitrate11$8,467
Fluocinonide37$1,314
Clobetasol Propionate26$1,186
Triamcinolone Acetonide150$1,117
Doxycycline Hyclate45$1,055
Mupirocin67$656
Hydrocortisone98$650
Clindamycin Phosphate17$495
Ketoconazole25$493
Selenium Sulfide17$372
ValacyclovirValacyclovir Hcl19$366
Cephalexin46$300
Acyclovir13$124
Prednisone11$55

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Irvine

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →